北京英诺特生物技术股份有限公司首次公开发行限售股上市流通公告

Core Viewpoint - The announcement details the upcoming listing and circulation of restricted shares for Beijing Innotech Biotechnology Co., Ltd., with a total of 67,647,516 shares set to be released on January 28, 2026, representing 49.3834% of the company's total share capital [1][13]. Group 1: Listing Details - The type of shares being listed is the first issuance of restricted shares, with a total of 67,647,516 shares available for circulation [1]. - The shares were initially issued on July 28, 2022, with a total share capital of 136,060,816 shares, of which 107,471,765 shares are restricted [1][3]. - The restricted shares will be released after a lock-up period of 42 months, extended from the original 36 months due to shareholder commitments [3]. Group 2: Shareholder Commitments - Major shareholders, including the actual controllers, have committed to not transferring their shares for 36 months post-listing, with additional conditions for any subsequent sales [5][10]. - The commitments include a stipulation that any share sales within two years after the lock-up period must not be below the initial offering price [10][11]. - The company has confirmed that all shareholders have adhered to their commitments, ensuring compliance with relevant regulations [12][13]. Group 3: Capital Structure Changes - The company's total share capital has changed from 136,060,816 shares to 136,458,196 shares due to the completion of the first vesting period of the 2023 restricted stock incentive plan [4]. - Further changes in share capital are expected as additional vesting periods are completed in the future [4]. Group 4: Regulatory Compliance - The underwriting institution, Huatai United Securities Co., Ltd., has verified that the listing of restricted shares complies with relevant laws and regulations [12][13]. - The announcement confirms that the information disclosed regarding the restricted shares is accurate and complete [13].